IMA is loading

Main Financial Data 2007

Main Data: 31/12 Year 2007
Consolidated income statement (international practice in accordance with IAS/IFRS) Millions/Euro
– total revenues 454.45
– gross industrial income 188.59
– total operating cost 118.95
– operating profit 69.64
– net financial expenses 7.71
– group profit 39.46

 

Consolidated balance sheet Millions/Euro
– working capital 70.71
– non-current assets 147.86
– provision for indemnities and other provisions – 21.60
– net debt – 86.61
– equity pertaining to the group and minority interests 110.36

 

Other information Millions/Euro
– depreciation, amortization and impairment 11.05
– R & D costs 22.18

 

  Euro
Dividend per share  0.85

 

  No.
Employees 2,629

 

  Euro
Share capital 17,732,000

 

Main Data: 30/06 Year 2007
Consolidated income statement (international practice in accordance with IAS/IFRS) Millions/Euro
– total revenues 209.6
– gross industrial income 87.1
– total operating cost 62.8
– operating profit 24.3
– net financial expenses 3.7
– group profit 11.3

 

Consolidated balance sheet Millions/Euro
– working capital 81.1
– non-current assets 144.9
– provision for severance indemnities and other provisions – 29.5
– net debt – 109.0
– equity pertaining to the group and minority interests 87.5

 

Other information Millions/Euro
– depreciation, amortization and impairment 5.5
– R & D costs 11.2

 

  No.
Employees 2,731

 

  Euro
Shares capital 18,772,000

 

Net sales by Sector: Year 2007  
  Millions/Euro  
 tea, herbs & coffee  77.07  17.0%
 pharmaceuticals packaging  248.53  54.6%
 pharmaceuticals processing  128.85  28.4%
 Total  454.45  100.0%

 

Net sales by Country: Year 2007
  Millions/Euro  
E.U. (excluding Italy) 183.46 40.4%
Other European countries 41.96 9.2%
North America 89.40 19.7%
Asia & Middle East 67.15 14.8%
Other countries 36.72 8.1%
Total exports 419.09 92.2%
Italy 35.36 7.8%
Total 454.45 100.0%